Literature DB >> 8457158

The economic impact of infections. An analysis of hospital costs and charges in surgical patients with cancer.

D J Shulkin1, B Kinosian, H Glick, C Glen-Puschett, J Daly, J M Eisenberg.   

Abstract

We performed an economic analysis of the care provided to patients undergoing major abdominal surgical procedures to determine the effect of postoperative infection on hospital resource use. Patients' clinical and demographic characteristics and their use of medical care services were determined from a review of hospital bills and medical records. Hospital charges were obtained from the hospital billing system and costs were determined by use of Medicare cost-charge ratios obtained from the hospital's Medicare Cost Report. The care of patients with postoperative infections was significantly more expensive than that of uninfected patients (multivariate analysis indicated that a surgical infection added $12,542 to the cost of patient care). Patients with postoperative fever but without documented infection were also more expensive to care for than afebrile, uninfected patients (fever added $9145 to the cost of care). Increased costs for infected patients were found among microbiology tests, radiology services, pharmaceutical costs, and room costs. For these patients, we found that use of departmental cost-charge ratios, instead of hospital-wide cost-charge ratios, had no substantial impact on comparison of the cost of care for infected and uninfected patients.

Entities:  

Mesh:

Year:  1993        PMID: 8457158     DOI: 10.1001/archsurg.1993.01420160091015

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  12 in total

1.  Complications of loop ileostomy closure in patients with rectal tumor.

Authors:  Takashi Akiyoshi; Yoshiya Fujimoto; Tsuyoshi Konishi; Hiroya Kuroyanagi; Masashi Ueno; Masatoshi Oya; Toshiharu Yamaguchi
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

Review 2.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

3.  Antibiotic policies. Economics and effectiveness from a UK perspective.

Authors:  P Davey
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.

Authors:  A M Craig; P Davey; M Malek; F Murray
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

Review 5.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

6.  Prospective randomized trial of two wound management strategies for dirty abdominal wounds.

Authors:  S M Cohn; G Giannotti; A W Ong; J E Varela; D V Shatz; M G McKenney; D Sleeman; E Ginzburg; J S Augenstein; P M Byers; L R Sands; M D Hellinger; N Namias
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

7.  The nutritional risk is a independent factor for postoperative morbidity in surgery for colorectal cancer.

Authors:  Seung-Jin Kwag; Jun-Gi Kim; Won-Kyung Kang; Jin-Kwon Lee; Seong-Taek Oh
Journal:  Ann Surg Treat Res       Date:  2014-03-25       Impact factor: 1.859

8.  Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.

Authors:  T J Babineau; P Marcello; W Swails; A Kenler; B Bistrian; R A Forse
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

9.  The economic burden of supportive care of cancer patients.

Authors:  Linda S Elting; Ya-Chen Tina Shih
Journal:  Support Care Cancer       Date:  2004-02-07       Impact factor: 3.603

10.  Evidence-based adoption of purse-string skin closure for stoma wounds.

Authors:  Nilotpal Behuria; Jayant Kumar Banerjee; Sita Ram Ghosh; Shrirang Vasant Kulkarni; Ramanathan Saranga Bharathi
Journal:  Med J Armed Forces India       Date:  2019-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.